SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology shares faced a significant sell-off following quarterly results, as investors expressed concern over compressed gross margins and the pace of future growth despite the company reporting an earnings beat and providing raised revenue guidance. While the drop sparked intense debate and volatility, many traders viewed the sharp decline as an overreaction and a potential buying opportunity, citing strong long-term fundamentals and the company's role in the AI connectivity market.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

The community is focused on the anticipation of a positive ALJ recommendation and subsequent DEA final ruling to move cannabis to Schedule III, viewing this as a critical catalyst for industry-wide tax relief and institutional adoption. While some traders express frustration with price suppression and algorithmic trading, others maintain a bullish long-term outlook, emphasizing that the current price remains undervalued relative to expected regulatory developments.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is seeing high market interest driven by its strong fiscal fourth-quarter results, beating Wall Street expectations for both earnings and revenue. While the stock initially retreated following the report, traders remain divided over the company's valuation and the role of acquisition-fueled versus organic revenue growth, even as analysts continue to issue bullish price target updates.

FuelCell Energy, Inc. is an American clean energy technology company that delivers continuous, scalable baseload power for mission-critical applications globally. It engages in the development, design, production, construction, operation, and servicing of high-temperature fuel cells for clean electric power generation. The company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emission power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems backed by global fuel cell deployments approaching one gigawatt. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy shares are experiencing volatility following a third-quarter earnings report that missed revenue and earnings expectations, primarily due to rising costs from data center project scaling and module delivery delays. Despite the financial miss and concerns regarding ongoing dilution, retail sentiment remains sharply divided as some traders emphasize long-term growth potential from the company's data center power pipeline and backlog.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Investors are largely dismissive of a recent Federal Circuit ruling invalidating several older patents, viewing it as a "nothing burger" because these assets were already considered lost at the PTAB level and are not part of the active, high-value litigation against Micron. Sentiment remains bullish as the community focuses on the upcoming September 9 oral arguments regarding the more critical 912 and 417 patents and the pending $445 million judgment.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell is trending after reporting strong quarterly results that exceeded expectations and raising its full-year outlook, driven by surging demand for AI-optimized servers. While retail sentiment remains optimistic regarding the company's long-term growth potential and record AI order backlog, traders are expressing frustration over intraday volatility and significant price swings, leading to debate over whether the stock is being manipulated or if investors are simply locking in profits.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake is trending as investors and traders closely monitor the stock ahead of its upcoming quarterly earnings report. While some traders are expressing bearish sentiment due to valuation concerns and insider selling, others remain bullish on the company's enterprise AI and data-cloud growth potential, highlighting recent analyst price target increases as a sign of continued institutional demand.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

LightPath Technologies is trending following a recent price pullback that community members attribute to broader sector volatility, momentum trading, and speculation regarding potential delays in the Next Generation Short Range Interceptor (NGSRI) program. While some traders express concern over the downward price action, others view the current levels as a buying opportunity based on the company's long-term backlog and critical role in the defense supply chain.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending as investors monitor anticipation for upcoming earnings, with sentiment divided between expectations of a strong AI-driven growth catalyst and concerns over volatility and management's past performance. Traders are actively debating whether current price levels offer a buying opportunity ahead of potential upside momentum.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

A large equity offering is driving the selloff and debate, with traders focused on dilution, the discounted pricing, and concerns that management weakened momentum. Bulls argue the raise provides permanent capital to expand capacity for strong AI-infrastructure and hyperscaler demand, while skeptics question the timing and near-term shareholder impact.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?

Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the successful completion of the acquisition of Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine...

Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?

NBIX's Crenessity gains rapid traction in CAH, with sales soaring and low patient penetration leaving room for growth.

If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 5.32% on an annualized basis producing an average annual return of 14.56%. Currently, Vertex Pharmaceuticals has a marketread more...

Vertex to Participate in Upcoming September Investor Conferences

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in four upcoming investor conferences. Susie Lisa, Senior Vice President of Investor Relations and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Wells...

Vertex Pharmaceuticals Up 15% in a Month: How to Play the Stock

Vertex's stock is up 15% in a month as strong CF sales, rising non-CF drug revenues and renal pipeline progress boost its growth story.

Vertex Pharmaceuticals: A Biotech Cash Cow With Pipeline Upside?

Explore the exciting world of Vertex Pharmaceuticals (NASDAQ: VRTX) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were...

Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead

Key PointsVertex Pharmaceuticals' business could be in trouble if it faces competition in its core market...

Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Crinetics Pharmaceuticals, Inc. (NasdaqGS: CRNX) to Vertex Pharmaceuticals Incorporated (NasdaqGS: VRTX). Under the terms of the proposed...

Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More

Key PointsVertex Pharmaceuticals appears likely to continue to dominate its core therapeutic area...

• Reported GAAP EPS of $4.34 up 7.96% YoY
• Reported revenue of $3.33B up 12.45% YoY
• Vertex Pharmaceuticals raised its full year 2026 total revenue guidance to $13.1 billion to $13.2 billion, while reiterating guidance for combined GAAP and non-GAAP R&D, AIPR&D, and SG&A expenses.

Vertex Pharmaceuticals experienced increased operating expenses and higher effective tax rates while facing structural risks regarding the successful commercialization of new therapies and potential delays in clinical and regulatory processes.

Vertex Pharmaceuticals delivered strong financial results with 12% revenue growth, highlighted by significant sequential revenue expansion for new products CASGEVY and JOURNAVX, alongside continued performance in cystic fibrosis therapies.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Current Price	$552.86
Prev Close	$547.65
Open	$551.48
Dividend Yield	0.00%
50-Day Moving Average	$504.02
Beta	0.53
Avg. Volume	1.2M
PE Ratio	31.86

52-Week High	$555.69
52-Week Low	$374.17
Market Capitalization	$138.81B
EPS (Annual)	$15.32
Price to Book	6.85
Revenue Per Employee	$1.89M

Feed

News

Sentiment

Earnings

Fundamentals

Info